January 30, 2019
Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies
Read More
January 30, 2019
Phase 3 Study of Sofosbuvir and Ribavirin
Read More
January 30, 2019
Phase 3 Study of Sofosbuvir and Ribavirin
Read More
X